BIOCRYST PHARMACEUTICALS INC·4

May 15, 7:19 AM ET

Doyle Anthony 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed May 15, 2024

Insider Transaction Report

Form 4
Period: 2024-05-14
Doyle Anthony
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2024-05-14$5.57/sh+36,300$202,191266,744 total

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT